ARCHIVES

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Komen Foundation Breast Cancer Awards

April 15, 1994

ASCO Strategic Plan Seeks To Increase Value to Members, Public

May 24, 2002

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009

Guest Editorial: Omics Checklist Done, Now Create Business Model For Tests

February 7, 2013

ACS California Division Offers Fellowships For Clinical Research

June 14, 1996

Frank Torti Named FDA Deputy Commissioner, To Take Leave As Wake Forest Center Director.

April 11, 2008